1. Home
  2. GTY vs NBTX Comparison

GTY vs NBTX Comparison

Compare GTY & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Getty Realty Corporation

GTY

Getty Realty Corporation

N/A

Current Price

$28.00

Market Cap

2.1B

Sector

Finance

ML Signal

N/A

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

N/A

Current Price

$23.70

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GTY
NBTX
Founded
1955
2003
Country
United States
France
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.7B
IPO Year
1998
2018

Fundamental Metrics

Financial Performance
Metric
GTY
NBTX
Price
$28.00
$23.70
Analyst Decision
Buy
Strong Buy
Analyst Count
8
5
Target Price
$35.57
★ $54.00
AVG Volume (30 Days)
★ 606.4K
135.5K
Earning Date
10-21-2026
09-24-2026
Dividend Yield
★ 6.95%
N/A
EPS Growth
★ 8.00
N/A
EPS
★ 0.79
N/A
Revenue
★ $221,727,000.00
N/A
Revenue This Year
$7.46
N/A
Revenue Next Year
$8.83
$50.69
P/E Ratio
$35.32
★ N/A
Revenue Growth
★ 9.02
N/A
52 Week Low
$25.39
$14.78
52 Week High
$36.83
$57.14

Technical Indicators

Market Signals
Indicator
GTY
NBTX
Relative Strength Index (RSI) 26.59 25.61
Support Level $27.08 $19.99
Resistance Level $33.90 $35.38
Average True Range (ATR) 0.47 1.78
MACD 0.04 -0.76
Stochastic Oscillator 28.91 9.65

Price Performance

Historical Comparison
GTY
NBTX

About GTY Getty Realty Corporation

Getty Realty Corp is a net lease real estate investment trust in the U.S.A, specializing in the acquisition, financing, and development of convenience, automotive, and other single-tenant retail real estate. The company's portfolio includes convenience stores, express tunnel car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, and collision), drive-thru quick service restaurants, and certain other freestanding retail properties. It generates maximum revenue in the form of rental income.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: